Beauty

This Serum Saved My Eye-Bags After Sleepless Nights

The easiest quick-fix.

By
10,495 Hypes

If you, like me, sometimes have a case of insomnia you definitely know the struggle of waking up in the morning with bright blue bags under your eyes. My under-eye area has always been naturally blue-ish, but when I started working more and staying up late a lot it got a lot worse. It wasn’t until a friend of mine recommended The Ordinary‘s Caffeine Solution that I found a quick fix for my sleepless nights.

The product is easy to use daily, just gently massage a few drops in your under-eye area both morning and night and after a few days you’ll without a doubt notice a difference. I’m not sure what kind of magic The Ordinary uses, but the website states that the serum contains “high 5% concentration of caffeine, supplemented with highly-purified Epigallocatechin Gallatyl Glucoside (EGCG) from green tea leaves.”

At $10.70 USD, the product also won’t break your bank. If you’re looking to try it out yourself, head over to The Ordinary’s website to cop.

Read Full Article

What to Read Next

Richardson Drops a Streetwear Ready FW18 Range
Fashion

Richardson Drops a Streetwear Ready FW18 Range

Must-have pieces.
843 Hypes

Le Labo's Tonka 25 Fragrance Is My New Go-To This Fall
Beauty 

Le Labo's Tonka 25 Fragrance Is My New Go-To This Fall

The perfect woody scent.
1,534 Hypes

Kappa's Latest Collection Is for the Disney Lovers
Fashion

Kappa's Latest Collection Is for the Disney Lovers

Celebrating Mickey Mouse’s 90th anniversary.
5,151 Hypes

5 Brands That Are Changing the Underwear Game With Period-Proof Panties
Fashion 

5 Brands That Are Changing the Underwear Game With Period-Proof Panties

Made for the everyday woman.
7,072 Hypes

Here Are the Highlights From the 2018 Victoria's Secret Fashion Show
Fashion

Here Are the Highlights From the 2018 Victoria's Secret Fashion Show

Starring Bella Hadid, Jasmine Tookes and more.
6,102 Hypes


More ▾
 
Subscribe to our Newsletter

Keep updated on the latest news.

By subscribing, you agree to our Terms of Use and Privacy Policy.